Expression of noradrenergic alpha1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16487641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.

  2005cited by this paper
• Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

  2004cited by this paper
• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  2004cited by this paper
• Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits.

  2003cited by this paper
• Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.

  2003cited by this paper
• Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs

  2003cited by this paper
• Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

  2003cited by this paper
• Mapping of 5‐HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies

  2001cited by this paper
• Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells

  2000cited by this paper
• Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

  2000cited by this paper
• D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.

  1999cited by this paper
• Induction of fos‐like‐immunoreactivity in the central extended amygdala by antidepressant drugs

  1999cited by this paper
• Region‐specific induction of ΔFosB by repeated administration of typical versus atypical antipsychotic drugs

  1999cited by this paper
• Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C (PKC) and phosphoinositide-specific phospholipase C (PI-PLC) activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain.

  1999cited by this paper
• Interaction of clozapine and other antipsychotic drugs with human alpha 1-adrenergic receptor subtypes.

  1999cited by this paper
• Brain Noradrenergic Receptors in Major Depression and Schizophrenia

  1999cited by this paper
• Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.

  1999cited by this paper
• New atypical antipsychotic medications.

  1998cited by this paper
• Phenotypic Characterization of Neuroleptic-Sensitive Neurons in the Forebrain: Contrasting Targets of Haloperidol and Clozapine

  1998cited by this paper
• Modulation of synaptic transmission by dopamine and norepinephrine in ventral but not dorsal striatum.

  1998cited by this paper
• Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain

  1998cited by this paper
• Activation of midline thalamic nuclei by antipsychotic drugs

  1998cited by this paper
• Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice.

  1997cited by this paper
• Regional and cellular distribution of serotonin 5‐hydroxytryptamine2a receptor mRNA in the nucleus accumbens, olfactory tubercle, and caudate putamen of the rat

  1997cited by this paper
• Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907

  1997cited by this paper
• Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

  1997cited by this paper
• Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum

  1996cited by this paper
• Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

  1996cited by this paper
• The thalamus as a site of action of antipsychotic drugs.

  1996cited by this paper
• In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.

  1995cited by this paper
• Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment.

  1995cited by this paper
• The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5HT2 receptor blockade to haloperidol.

  1995cited by this paper
• Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action.

  1995cited by this paper
• Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.

  1995cited by this paper
• Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.

  1994cited by this paper
• Clozapine response and plasma catecholamines and their metabolites.

  1993cited by this paper
• Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.

  1993cited by this paper
• Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain.

  1993cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.

  1992cited by this paper
• Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.

  1992cited by this paper
• Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

  1992cited by this paper
• Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

  1990cited by this paper
• Neuroleptic dosage regimens in psychotic inpatients: a retrospective comparison.

  1990cited by this paper
• Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

  1989cited by this paper
• Profile of in Vitro Binding Affinities of Neuroleptics at Different Rat Brain Receptors: Cluster Analysis Comparison with Pharmacological and Clinical Profiles

  1989cited by this paper
• Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

  1988cited by this paper
• In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.

  1986cited by this paper
• Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

  1985cited by this paper
• Impaired noradrenergic transmission in schizophrenia?

  1984cited by this paper
• Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.

  1984cited by this paper
• Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

  1984cited by this paper
• Dissimilar dosing with high-potency and low-potency neuroleptics.

  1984cited by this paper
• Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

  1980cited by this paper
• Schizophrenia: elevated cerebrospinal fluid norepinephrine.

  1980cited by this paper
• Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites.

  1979cited by this paper
• Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients

  1976cited by this paper

• The α1-adrenergic receptors in the amygdala regulate the induction of learned despair through protein kinase C-beta signaling.

  2020cites this paper
• Pharmacological analysis of the mechanisms underlying seizure induction mediated by nicotinic acetylcholine receptors (ニコチン性アセチルコリン受容体を介するけいれん発作発現メカニズムの薬理解析)

  2018cites this paper
• Dual‐radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D2/3 and 5‐HT2A receptors

  2018cites this paper
• Etiopatogeneza metaboličkog sindroma u shizofreniji – najnovije spoznaje

  2017cites this paper
• Immunohistochemical Analysis of Fos Protein Expression for Exploring Brain Regions Related to Central Nervous System Disorders and Drug Actions

  2017cites this paper
• A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.

  2016cites this paper
• Simultaneous activation of the α1A-, α1B- and α1D-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats.

  2015cites this paper
• Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs

  2014cites this paper
• Deep Brain Stimulation of the Subthalamic and Entopeduncular Nuclei in an Animal Model of Tardive Dyskinesia

  2013cites this paper
• Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating

  2011cites this paper
• Cardiac and neuroprotection regulated by α1-adrenergic receptor subtypes

  2011cites this paper
• Ventral Striatal Noradrenergic Mechanisms Contribute to Sensorimotor Gating Deficits Induced by Amphetamine

  2010cites this paper
• Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors.

  2010cites this paper
• Kappa-opioid ligands in the study and treatment of mood disorders.

  2009cites this paper
• Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia.

  2009cites this paper
• Potential Utility of Kappa Ligands in the Treatment of Mood Disorders

  2009cites this paper
• An investigation of the α1A‐adrenergic receptor gene and antipsychotic‐induced side‐effects

  2008influential citation
• An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells

  2008cites this paper
• CART peptides increase 5-hydroxytryptamine in the dorsal raphe and nucleus accumbens of freely behaving rats.

  2007cites this paper
• Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach

  2007cites this paper
• An Animal Model of Emotional Blunting in Schizophrenia

  2007cites this paper
• Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.

  2006cites this paper